{7 (ethinyl estradiol 0.025 mg / norgestimate 0.18 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.215 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.25 mg Oral Tablet) / 7 (inert ingredients 1 mg Oral Tablet) } Pack [Tri-Lo_Sprintec]
RxNorm 856466

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 856466 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: {7 (ethinyl estradiol 0.025 mg / norgestimate 0.18 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.215 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.25 mg Oral Tablet) / 7 (inert ingredients 1 mg Oral Tablet) } Pack [Tri-Lo_Sprintec].

The following semantic concepts and normalized strings are associated with this clinical entity:

BPCK
{7 (ethinyl estradiol 0.025 mg / norgestimate 0.18 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.215 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.25 mg Oral Tablet) / 7 (inert ingredients 1 mg Oral Tablet) } Pack [Tri-Lo_Sprintec]
AUI:12373026

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

BPCK

Brand Name Pack (BPCK):
{7 (ethinyl estradiol 0.025 mg / norgestimate 0.18 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.215 mg Oral Tablet) / 7 (ethinyl estradiol 0.025 mg / norgestimate 0.25 mg Oral Tablet) / 7 (inert ingredients 1 mg Oral Tablet) } Pack [Tri-Lo_Sprintec]
(Atom ID: 12373026)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Lo_Sprintec]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
856466
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12373026
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
856466
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260504F
The specific version of the vocabulary provided by the source.
Update Date
May 04, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete